The development of a national system for drug monitoring in Spain is described. The pharmaceutical market in many European countries is very different from that in other regions (eg, the Nordic Countries or the UK) with a tradition in drug surveillance activities. This paper focuses on the coordinated development of drug information and drug surveillance activities in a model country where a rational drug policy is urgently needed. © 1985, Drug Information Association. All rights reserved.
|Journal||Therapeutic Innovation & Regulatory Science|
|Publication status||Published - 1 Jan 1985|
- Drug selection
- Drug surveillance
- Spontaneous reporting